FEDERATED HERMES, INC.

Position in IBRX — ImmunityBio, Inc.

CIK 1056288 PITTSBURGH, PA

Position in IBRX

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$14,999,065

+$4,363,913 QoQ

Shares Held

1,713,200

+23.6% QoQ

Ownership

0.162%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#19

of 403 holders

Holding Since

Jun 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

FEDERATED HERMES, INC. holds $2,455,215,104 across 149 Biotechnology names. IBRX ranks #40 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	719,905	$216,713,000
2	RYTM	Rhythm Pharmaceuticals, Inc.	1,785,716	$198,268,046
3	REGN	Regeneron Pharmaceuticals, Inc.	256,884	$160,177,448
4	MRNA	Moderna, Inc.	1,794,778	$125,688,301
5	KYMR	Kymera Therapeutics, Inc.	749,398	$85,933,468
6	EYPT	EyePoint, Inc.	5,681,052	$81,239,042
7	ARGX	Argenx SE	87,288	$80,983,187
8	ZBIO	Zenas BioPharma, Inc.	3,116,805	$79,104,510

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$14,999,065	1,713,200	+23.6%	Shares	Defined	2026-08-12
2026-03-31	$10,635,152	1,386,591	+700198.5%	Shares	Defined	2026-05-11
2024-03-31	$1,063	198	+0.5%	Shares	Defined	2024-05-14
2023-12-31	$988	197	-24.2%	Shares	Defined	2024-01-31
2023-09-30	$439	260	-98.3%	Shares	Defined	2023-11-13
2023-06-30	$43,798	15,755	-28.4%	Shares	Defined	2023-08-14
2023-03-31	$40,052	22,007	+1001.5%	Shares	Defined	2023-05-08
2022-03-31	$11,208	1,998	+0.2%	Shares	Defined	2022-05-13
2021-12-31	$12,129	1,995	-55.9%	Shares	Defined	2022-02-14
2021-09-30	$44,063	4,524	-0.7%	Shares	Defined	2021-11-15
2021-06-30	$65,088	4,558	+4854.3%	Shares	Defined	2021-08-16
2021-03-31	$2,184	92	—	Shares	Defined	2021-05-13
2020-06-30 NK	—	175	—	Shares	Defined	2020-08-13
No filing history on record for this holder in this stock.